Projects
The pharmaceutical projects listed in this phase are those that receive periodic global announcements.
Octapharma Announces US$1.5 Billion Plasma Manufacturing Facility in South Carolina
Octapharma has announced plans to develop its first USbased manufacturing and production facility at Palmetto Research Park in Rock Hill, South Carolina, with an investment of US $15 billion
BeOne Medicines Invests US$300 Million to Expand New Jersey Manufacturing Campus
BeOne Medicines has announced a US$300 million expansion of its Princeton West Innovation Campus in Hopewell, New Jersey, strengthening its US manufacturing and research capabilities
Piramal Pharma Solutions Announces US$90 Million Expansion of U.S. CDMO Facilities
Piramal Pharma Solutions has announced a $90 million investment to expand its manufacturing facilities in Riverview, Michigan, and Lexington, Kentucky, as part of its strategy to strengthen
Siemens Invests $14 Million in Drummondville Plant Expansion to Advance Digital Manufacturing
Siemens Canada has completed a major expansion and modernisation project at its manufacturing facility in Drummondville, Qubec The yearlong project represents an investment of approximately US$14 million
Hikma Pharma Invests $267M to Expand Ohio Manufacturing Operations
Hikma Pharmaceuticals has announced a major expansion of its manufacturing operations in Ohio, USA, with a total investment of $267 million
Vetter Invests €500 Million to Expand New Saarlouis Injectable Drug Manufacturing Facility
Vetter has started construction of its new pharmaceutical manufacturing facility in Saarlouis, Germany, supported by an investment of nearly 500 million The project will expand the companys commercial manufacturing capabilities for injectable medicines and support increasing global demand for complex drug products
Novartis Invests $23 Billion to Expand New Texas Radioligand Therapy Facility
Novartis has started construction on a new 46,000 sq ft radioligand therapy RLT manufacturing facility in Denton, Texas, as part of its wider $23 billion investment programme in the United States
Amgen Announces Additional $300 Million to Expand Puerto Rico Manufacturing Operations
Amgen has announced an additional investment of $300 million to expand its manufacturing operations in Puerto Rico The latest investment brings Amgens recently announced commitments in Puerto Rico to nearly $1 billion
PCI Pharma Services Expands Global Manufacturing Network with $1B+ Investment in San Diego
PCI Pharma Services has announced an investment programme exceeding $1 billion across its US and European operations to strengthen sterile fillfinish and advanced drug delivery capabilities
Novartis Announces $23 Billion Investment to Expand API Manufacturing Facility in North Carolina
Novartis has announced plans to develop a new 56,200squarefoot manufacturing facility in Morrisville, North Carolina, as part of its wider $23 billion investment in USbased manufacturing and research
